The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection

Transplantation

Volumn 83, Issue 3, 2007, Pages 341-346

  Grimbert, Philippe ^a   Mansour, Hicham ^a   Desvaux, D ^a   Roudot Thoraval, Françoise ^a   Audard, Vincent ^a   Dahan, Karine ^a   Berrehar, François ^a   Dehoulle Poillet, Catherine ^a   Farcet, Jean Pierre ^a   Lang, Philippe ^a   Le Gouvello, Sabine ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Acute rejection; Borderline change; Foxp3; Renal transplantation

Indexed keywords

GRANZYME B; INTERLEUKIN 10; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; LYMPHOCYTIC INFILTRATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

BIOLOGICAL MARKERS; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRANZYMES; HUMANS; INTERLEUKIN-10; KIDNEY TRANSPLANTATION; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 33846947524     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000248884.71946.19     Document Type: Article

References (19)

1. Furness PN, Kirkpatrick U, Taub N, Davies DR, Solez K. A UK-wide trial of the Banff classification of renal transplant pathology in routine diagnostic practice. Nephrol Dial Transplant 1997; 12: 995.
2. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
3. Strom TB, Suthanthiran M. Prospects and applicability of molecular diagnosis of allograft rejection. Semin Nephrol 2000; 20: 103.
4. Nickel P, Lacha J, Ode-Hakim S, et al. P. Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft. Transplantation 2001; 72: 1160.
5. Desvaux D, Schwarzinger M, Pastural M, et al. Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation 2004; 78: 647.
6. Kaminska D, Tyran B, Mazanowska O, et al. Intragraft mRNA expression of cytokines and growth factors in human kidney allograft biopsies by in situ RT-PCR analysis. Transplant Proc 2005; 37: 767.
7. Hribova P, Kotsch K, Brabcova I, Vitko S, Volk HD, Lacha J. Cytokines and chemokine gene expression in human kidney transplantation. Transplant Proc 2005; 37: 760.
8. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345.
9. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003; 171: 6323.
10. Walsh PT, Taylor DK, Turka LA. Tregs and transplantation tolerance. J Clin Invest 2004; 114: 1398.
11. Mesel-Lemoine M, Cherai M, Le Gouvello S, et al. Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy. Blood 2006; 1: 381.
12. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342-2351.
13. Strom TB. Is transplantation tolerable? J Clin Invest 2004; 113: 1681.
14. Louis S, Braudeau C, Giral M, et al. Contrasting CD25hiCD4+T cells/ FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398.
15. Woo EY, Chu CS, Goletz TJ, et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001; 61: 4766.
16. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942.
17. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005; 102: 18538.
18. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641.
19. Meehan SM, Siegel CT, Aronson AJ, et al. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol 1999; 10: 1806.